Consumer Cyclical
Live Price
Offline$577.96
-0.56% today
1Y Change
+39.98%
Window
Jun 27, 2025 → Jun 24, 2026
Coverage: 248 bars · Jun 27, 2025 → Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Dillard's Inc. (DDS) is a Consumer Cyclical stock with a market cap of $8.73B and listed on NYSE. The stock last traded around $577.96 and up 40.0% across the available one-year price window (Jun 27, 2025 → Jun 24, 2026). Baseline metrics include revenue growth of -0.4%, EPS growth of -1.0%, a dividend yield of 5.6%. What stands out right now is revenue -0.4%, EPS -1.0%, free cash flow +2.3% with operating margin 10.5% and ROIC 20.9%. The dividend matters to the case here, with a current yield around 5.6%. Valuation is more restrained than many high-expectation growth names at P/E 15.3 and price/sales 1.3. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines DDS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
DDS is 20.74 pts ahead over the shared 1Y window.
DDS had 18.33 pts deeper max drawdown than SPY.
DDS beat SPY in 1 of 2 calendar years shown and trailed in 1.
DDS
+39.98%
Normalized return
SPY
+19.24%
S&P 500
Excess Return
+20.74 pts
Relative to SPY
DDS Max Drawdown
-27.46%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for DDS and SPY.
| Year | DDS | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -8.70% | +6.71% | -15.41 pts | SPY |
| 2025 | +47.46% | +11.73% | +35.73 pts | DDS |
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$6.6B
-5.3% YoY
FY Net Income
$862.5M
-3.3% YoY
Free Cash Flow
$1.2B
+41.9% YoY
Revenue Growth
-0.4%
EPS Growth
-1.0%
Gross Margin
38.3%
Net Margin
8.7%
Income statement
USD
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 6.6B | 6.6B | 6.9B | 7.0B | 6.6B |
| Gross Profit | 2.5B | 2.7B | 2.8B | 3.0B | 2.9B |
| Operating Income | 689M | 740M | 925M | 1.1B | 1.1B |
| EBITDA | 874M | 949M | 1.1B | 1.3B | 1.3B |
| Net Income | 571M | 593M | 739M | 892M | 862M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | 862M | 718M | 808M | 650M | 717M |
| Total Assets | 3.5B | 3.5B | 3.4B | 3.3B | 3.2B |
| Total Liabilities | 1.7B | 1.7B | 1.8B | 1.7B | 1.8B |
| Shareholder Equity | 1.8B | 1.8B | 1.7B | 1.6B | 1.5B |
| Total Debt | 558M | 555M | 564M | 555M | 609M |
| Net Debt | -304M | -163M | -244M | -95M | -108M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1.3B
+35.0% YoY
Capital Expenditures
104M
+13.1% YoY
Free Cash Flow
1.2B
+41.9% YoY
Key ratios
Gross Margin
38.3%
Operating Margin
10.5%
Net Margin
8.7%
ROE
30.0%
Debt / Equity
0.31x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.